Nosocomial Infections

1
Nosocomial Infections

• Patrick Kimmitt

2
Today we are going to cover

• The factors that contribute to nosocomial
  infections
• Examples of nosocomial infections and the
  organisms which cause them
• Control of nosocomial infections
• Surveillance of nosocomial infections

3
Nosocomial infections are

• Infections that are acquired in hospital (48
  hours or more after admission)
• Approx 9 of patients will suffer from an
  infection whilst in hospital risk increases
  with length of stay
• Significant financial burden on NHS

4
Impact of nosocomial infections

• 100,000 infections per year in UK
• 5,000 deaths with nosocomial infections playing a
  role in 15,000 others
• Costs the NHS 1 billion 9 of its in-patient
  budget
• Cannot eradicate but its thought they could be
  reduced by up to 30 (saving 300,000,000!)

5
(No Transcript)
6
Why are we more likely to get an infection in
hospital?

• Consider 4 important factors
• The host
• The microbes
• The environment
• Treatment

7
The host 1

• People in hospital are already sick!
• They may have poor general resistance to
  infection
• Lack of immunity
• Extremes of age
• Immunocompromised (eg HIV, cancer chemotherapy)

8
The host 2

• Reduced immunity
• Diabetes, severe burns
• Poor local resistance
• Poor blood supply to tissues
• Surgery
• Wounds, sutures
• Medical devices
• Catheters, prostheses, tubing etc

9
The microbes

• Virtually any infection can be acquired in
  hospital
• However a number of usual suspects predominate
• What are they, where do they come from and why do
  they cause nosocomial infection?

10
Opportunistic infections

• Nosocomial infections are often caused by
  opportunistic pathogens i.e. those which do not
  normally cause infection in healthy people
• May be a reflection of reduced defences of host
  or access to sites not normally colonised by
  organisms
• May be from normal flora or environment
• Antibiotic resistance is a problem

11
Opportunistic pathogens

• Pseudomonas aeruginosa
• staphylococci
• E. coli and other coliforms
• streptococci and enterococci
• Bacteroides fragilis
• Candida albicans
• Herpes simplex virus
• Cytomegalovirus

12
Biofilms

• Biofilms are microbial communities (cities)
  living attached to a solid support eg catheters/
  other medical devices
• Biofilms are involved in up to 60 of nosocomial
  infections
• Antibiotics are less effective at killing
  bacteria when part of a biofilm

13
The Environment

• There are many different sources of pathogens
  when in hospital
• Own normal flora (endogenous)
• Infected patients
• Traffic of staff and visitors
• Environment e.g. fungi, Legionella
• Blood products
• Surgical instruments eg vCJD

14
Treatment

• There is continuous usage of antibiotics in
  hospitals especially in ICU
• As a result there will be a natural selection for
  strains that are antibiotic resistant
  infections are getting harder to treat
• This has led to problems with multi-resistant
  bacteria e.g. MRSA, VRE, ESBLs
• Antibiotic treatment can also lead to alterations
  in normal flora and allow pathogens cause
  infection eg C. difficile

15
(No Transcript)
16
Types of nosocomial infection and their causes

• Data from a single study 1992-97 from a
  paediatric ICU and excluding viral infections
• Source http//www.emedicine.com/ped/topic1619.ht
  msectionclinical

17
Bloodstream nosocomial infections

• Coagulase-negative staphylococci, 40
• Enterococci, 11.2
• Fungi, 9.65
• Staphylococcus aureus, 9.3
• Enterobacter species, 6.2
• Pseudomonads, 4.9
• Acinetobacter baumannii with substantial
  antimicrobial resistance - Reported with
  increasing frequency

18
Urinary Tract Infections

• Gram-negative enterics, 50
• Fungi, 25
• Enterococci, 10

19
Surgical site infections

• S aureus, 20
• Pseudomonads, 16
• Coagulase-negative staphylococci, 15
• Enterococci, fungi, Enterobacter species, and
  Escherichia coli, less than 10 each

20
Causes of death

• Primary bloodstream infection
• Pneumonia
• Infection of surgical site

21
MRSA

• Methicillin (Meticillin) Resistant Staphylococcus
  aureus
• S aureus carried by 30 of us (nose/ skin)
• MRSA is no more virulent than MSSA strains but
  more difficult to treat
• Resistance due to mecA gene encodes PBP2a,
  doesnt react with Penicillins
• Emerging Vancomycin resistance is a concern
• The Biomedical Scientist Jan 2008 p39-41

22
Epidemic MRSA (EMRSA)

• 1984 EMRSA-1 identified in many hospitals in
  London and south-east England.
• Subsequent surveys showed further 13
  multi-hospital MRSA (EMRSA-2 to -14)
• Mid-1990s EMRSA-15 and -16 emerged and spread
  widely
• 591 MRSA isolates received between 1998 and 2000,
  60 EMRSA-15, 35 EMRSA-16

23
Rapid MRSA screening

• Current methods for screening for MRSA are based
  on culture and take 48 hours
• PCR-based screening can generate a result in 2
  hours!
• mecA is carried on a transferable gene cassette
  called SCCmec but also found in
  coagulase-negative staphylococci
• PCR developed using primers for SCCmec and orfX
  on the S. aureus chromosome

24
Use of SCCmec/orfX PCR
MRSA
No PCR product
MSSA
orfX
No PCR product
MR CN-Staph
mecA
SCC 3 end
Cuny Witte Clin Microbiol Infect (2005)
11834-837
25
Extended spectrum ß-Lactamases

• ESBLs are responsible for resistance to 3rd
  generation Cephalosporin antibiotics such as
  Ceftazidime and Cefotaxime
• Resistance is found in E. coli and other members
  of the Enterobacteriacae
• Often cross-resistance with other antibiotics
  making treatment difficult use imipenem

26
Clostridium difficile

• Causes antibiotic-associated diarrhoea and
  pseudomembranous colitis life-threatening
  illnesses
• Normally affects only the elderly, especially
  those on long-term broad-spectrum antibiotics
• Produces two powerful toxins and is a
  spore-former difficult to eradicate, resistant
  to alcohol
• Reasons for recent increases still not known

27
Clostridium difficile

• Nosocomial disease spread primarily by hands of
  staff and outbreaks are common
• Patients generally respond to discontinuation of
  the inciting agent or therapy with metronidazole
  or vancomycin. Response is rapid but Mtz and Vanc
  may also alter normal flora and may allow disease
  to recur
• Once the colon is injured it is more susceptible
  to re-infection. Relapse rates are up to approx
  20
• Almost impossible, at present, to rid the
  environment of C. difficile spores
• Some use 1000-10000ppm hypochlorite highly
  caustic and damaging to surfaces. There may be
  rapid re-contamination of environment.

28
Nosocomial transmission of C. difficile

• Contamination rates after contact with CDAD
  patients
• Physicians medical Students
  75 of the time
• Dialysis Technicians
  66 of the time
• Nurses
  56 of the time
• Physiotherapists
  50 of the time
• Underside of fingernails
  43
• Fingertips and Palms
  37
• Underside of Rings
  20
• C difficile spores remain in environment in
  34-58 of sites after detergent cleaning
• CDC 2005

29
Success story

• Scunthorpe and Goole NHS trust looked at changing
  their antibiotic prescribing policy to reduce the
  incidence of C. difficile disease
• Cost 12,000 extra to implement
• Saved 280,000 in staffing, bed occupancy,
  treatment, use of isolation rooms etc, oh, and
  some lives!

30
Infection Control

• Infections may derive from endogenous
  (auto-infection) or exogenous sources
  (cross-infection)
• We need to consider the chain of infection and
  the transmission of an infectious agent

31
Transmission

• Contact most common
• Direct (physical contact)
• Indirect (via contaminated objects)
• Airborne Transmission
• Droplet respiratory secretions on surfaces
• Inhalation of infectious particles
• Blood-borne transmission
• Food-borne

32
Role of infection control teams

• Education and training
• Development and dissemination of infection
  control policy
• Monitoring and audit of hygiene
• Clinical audit

33
(No Transcript)
34
Surveillance

• Continuous monitoring of the frequency and
  distribution of infectious diseases
• Determines the most important causes of
  infectious diseases and identifies at risk groups

35
Uses of surveillance

• Used to identify new problems
• Used to identify where resources are most needed
• Used to determine the burden of disease
• Used for strategic planning and policies
• Use surveillance for measuring outcomes of
  intervention strategies

36
Epidemiology

• Surveillance is also used to detect epidemics and
  outbreaks
• Epidemiologists at Centre for Infections analyse
  data sent from laboratories throughout the
  country

37

• Surveillance reports published in CDR weekly
  http//www.hpa.org.uk/cdr/index.html
• But how do Biomedical Scientists help with this
  work?
• Isolating and identifying the pathogens -
  hospitals
• Typing specialist laboratories

38
Typing of pathogens

• There are many different strains of a bacterial/
  fungal/ viral species so in order to identify a
  possible outbreak and identify the source we need
  to discriminate between organisms of the same
  species
• This is called typing there are a number of
  methods available
• Those based on phenotype (traditional)
• Those based on genotype (recent)

39
Typing methods

• Typing is usually performed at specialised
  Reference Laboratories such as those at HPA
  Centre for Infections
• Different methods are used for different
  pathogens use the one which gives best
  discrimination
• Pathogens of the same type may be part of an
  outbreak, if they are of a different type an
  outbreak can be ruled out

40
Phage Typing

• Phage (bacteriophage) is a virus that infects and
  kills bacteria
• Different strains are susceptible to different
  phages
• Gives a fingerprint that can discriminate between
  strains
• Used in the typing of S. aureus and Salmonella

41
Serotyping

• Used to detect variations in certain antigens
  present on the pathogen
• Use specific antisera and observe a
  Antibody-Antigen reaction (usually a
  precipitation or agglutination reaction)
• Eg Streptococcus pyogenes M-protein typing M1
  type is important in invasive infections (flesh
  eating etc)
• H and N typing of influenza eg H5N1

42
Colicine typing

• Colicines (bacteriocins) are produced by certain
  bacterial species that inhibit the growth of
  other members of the same species
• Look for patterns of sensitivity/ resistance with
  different colicines
• Eg Pseudomonas

43
Biotyping

• Biotyping explores the metabolism of an organism
  eg a particular enzyme activity or ability to
  ferment a particular sugar
• Eg. coagulase-negative staphylococci

44
Genotyping

• There are a number of methods available most
  rely on sequence variation in non-coding
  (intergenic) DNA
• This variation is characteristic of a particular
  strain (or type)
• Strains from an outbreak will be the same type
• Similar to DNA fingerprinting used in CSI and
  paternity disputes

45
Restriction Fragment Length Polymorphism (RFLP)

• DNA extracted from bacterial isolates is digested
  (cut) with a restriction enzyme eg EcoR I
• Produces DNA fragments of varying size gel
  electrophoresis
• Pattern of bands is strain-specific

46
Pulsed Field Gel Electrophoresis

• Used to separate large DNA fragments gt10 kb
• Chromosomal DNA digested with restriction enzyme
  and fragments separated by PFGE
• Banding pattern is strain specific used e.g in
  MRSA typing

47
Summary 1

• Can you explain in detail why patients in
  hospital are more prone to infection?
• Can you define a primary and an opportunistic
  pathogen?
• Can you give examples of nosocomial infections,
  with predisposing factors and examples of the
  pathogens which cause them?
• Can you discuss infections due to MRSA and C.
  difficile in detail?

48
Summary 2

• 5. Can you discuss the transmission of infection
  in hospitals, uses of infection control and the
  role of infection control teams?
• Why is surveillance of nosocomial infections
  important?
• What is the role of the laboratory in the
  diagnosis and surveillance of nosocomial
  infections?
• Can you give examples of the methods used in the
  laboratory for diagnosis and surveillance of
  nosocomial infections?